Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.3080
+0.0035 (1.15%)
At close: Dec 9, 2025, 4:00 PM EST
0.3002
-0.0078 (-2.53%)
After-hours: Dec 9, 2025, 7:59 PM EST
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $7.39 million as of December 9, 2025. Its market cap has increased by 13.07% in one year.
Market Cap
7.39M
Enterprise Value
2.78M
1-Year Change
13.07%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.34M to $7.39M, a decrease of -71.95%. That is a compound annual growth rate of -15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 7.39M | 12.98% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.56M | 131.14% |
| Dec 31, 2020 | 24.47M | -1.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |